Core Insights - Teladoc Health reported a net loss of 1,001.2millionforthefullyear2024,significantlyhigherthanthe220.4 million loss in 2023, primarily due to a non-cash goodwill impairment charge of 790millionrelatedtotheBetterHelpsegment[7][13][12]−Thecompanyexperienceda12,569.6 million compared to 2,602.4millionin2023[7][11]−IntegratedCaresegmentrevenueincreasedby4640.5 million from 660.5millioninthesamequarterof2023[6][7]−ThenetlossforFourthQuarter2024was48.4 million, compared to a loss of 28.9millioninFourthQuarter2023[8][7]−AdjustedEBITDAforFourthQuarter2024was74.8 million, down 35% from 114.4millioninFourthQuarter2023[9][15]RevenueBreakdown−AccessfeesrevenueforFourthQuarter2024decreasedby5543.1 million, while other revenue grew by 12% to 97.4million[6][11]−U.S.revenuedecreasedby5535.4 million, while international revenue grew by 10% to 105.1millioninFourthQuarter2024[6][11]−Forthefullyear2024,U.S.revenuedecreasedby32,160.0 million, while international revenue increased by 12% to 409.6million[11][12]CostandCashFlow−Operatingcashflowforthefullyear2024was293.7 million, down from 350.0millionin2023[7][17]−Freecashflowforthefullyear2024was169.6 million, compared to 193.7millionin2023[7][18]−Capitalexpendituresforthefullyear2024were124.1 million, down from 156.3millionin2023[18]FutureOutlook−Forthefullyear2025,Teladocexpectsrevenueintherangeof2,468 million to 2,576millionandadjustedEBITDAbetween278 million and 319million[19][20]−Thecompanyanticipatesanetlosspersharefor2025intherangeof(1.10) to ($0.50) [20][21] - The guidance includes contributions from the acquisition of Catapult Health, expected to close at the end of February 2025 [19][20]
Teladoc(TDOC) GlobeNewswire·2025-02-26 21:05